Candid On Cancer: Interview with Penn Medicine's Dr. Robert Vonderheide - Bench to Bedside
Penn Medicine's Abramson Cancer Center incorporates a bench to bedside approach to treating cancer that keeps providers at the patient's bedside connected to the researchers in the lab developing the therapies. In this video Dr. Robert Vonderheide, Director of the Abramson Cancer Center explains what bench to bedside means and how it impacts the patients treated at Penn.
BROADCASTMED